Clinical trialNAUnknown
Personalized Precision Diagnosis and Treatment of Pancreatic Cancer
A Single-centric, Prospective, Open, Interventional Clinical Trial, About Personalized Precision Diagnosis and Treatment of Pancreatic Cancer
- Outcome
- Outcome unknown
- Phase
- NA
- Status
- Unknown
- Study type
- Interventional
- Start
- 10 November 2017
- Expected end
- 31 December 2024
- Enrollment
- 100 participants
- Sites
- 1
- Primary outcomes
- OS
- Sponsor
- Other
- Results posted
- No
- Last update
- 1 September 2023
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 5
- BackgroundDetection of circulating tumor DNA in early- and late-stage human malignancies. DOI 10.1126/scitranslmed.3007094↗
- BackgroundConditionally reprogrammed cells represent a stem-like state of adult epithelial cells. DOI 10.1073/pnas.1213241109↗
- BackgroundRelationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients … DOI 10.1200/jco.2007.15.8923↗
- BackgroundCirculating tumor cells, disease progression, and survival in metastatic breast cancer. DOI 10.1056/nejmoa040766↗
- BackgroundClonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for a… DOI 10.1016/j.ejca.2004.01.009↗